[Clinical study of bisphosphonates for bone metastasis in breast cancer].
Yamada
Kimito
K
Department of Breast Oncology, Tokyo Medical University.
Kohno
Norio
N
D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D001859:Bone Neoplasms / Q000150:complications / Q000517:prevention & control / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology*; D004164:Diphosphonates / Q000008:administration & dosage*; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage; D010010:Osteoclasts / Q000502:physiology; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D000077268:Pamidronate; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077268:Pamidronate